Does systemic leukocyte filtration affect perioperative hemorrhage in cardiac surgery? A systematic review and meta-analysis

ASAIO Journal

Volumn 53, Issue 4, 2007, Pages 514-521

  Warren, Oliver ^a   Wallace, Sophie ^a   Massey, Rachel ^a   Tunnicliffe, Caroline ^a   Alexiou, Christos ^a   Powell, John ^b   Meisuria, Narendra ^b   Darzi, Ara ^a   Athanasiou, Thanos ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CELLS; COAGULATION; FILTERS (FOR FLUIDS); PATIENT MONITORING; PULMONARY DISEASES;

BYPASS CIRCULATION; INFLAMMATORY REACTION; LEUKOFILTRATION; META-ANALYSIS;

CARDIOLOGY;

BLEEDING; BLOOD CLOTTING DISORDER; CARDIOPULMONARY BYPASS; CELL SEPARATION; ERYTHROCYTE TRANSFUSION; HEART SURGERY; HUMAN; INFORMATION RETRIEVAL; LEUKOCYTE; LEUKOCYTE FILTRATION; MATHEMATICAL MODEL; PERIOPERATIVE PERIOD; REVIEW; SENSITIVITY ANALYSIS; SURGICAL DRAINAGE; SYSTEMATIC REVIEW;

BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; HEMORRHAGE; HUMANS; LEUKOCYTE REDUCTION PROCEDURES;

EID: 34547662959     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e31805c15f9     Document Type: Review

References (58)

1. Wan S, LeClerc JL, Vincent JL: Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies. Chest 112: 676-692, 1997.
2. Cremer J, Martin M, Redl H, et al: Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61: 1714-1720, 1996.
3. Elgebaly SA, Houser SL, el Kerm AF, et al: Evidence of cardiac inflammation after open heart operations. Ann Thorac Surg 57: 391-396, 1994.
4. Edmunds LH Jr: The evolution of cardiopulmonary bypass: Lessons to be learned. Perfusion 17: 243-251, 2002.
5. Edmunds LH Jr: Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 66: S12-S16; discussion S25-S18, 1998.
6. Asimakopoulos G, Smith PL, Ratnatunga CP, Taylor KM: Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg 68: 1107-1115, 1999.
7. Paparella D, Brister SJ, Buchanan MR: Coagulation disorders of cardiopulmonary bypass: A review. Intensive Care Med 30: 1873-1881, 2004.
8. ten Cate JW, van der Poll T, Levi M, ten Cate H, van Deventer SJ: Cytokines: Triggers of clinical thrombotic disease. Thromb Haemost 78: 415-419, 1997.
9. Ernofsson M, Thelin S, Siegbahn A: Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: A clinical study. J Thorac Cardiovasc Surg 113: 576-584, 1997.
10. Ishihara K, Oshida H, Endo Y, et al: Hemocompatibility of human whole blood on polymers with a phospholipid polar group and its mechanism. J Biomed Mater Res 26: 1543-1552, 1992.
11. Bando K, Schueler S, Cameron DE, et al: Twelve-hour cardiopulmonary preservation using donor core cooling, leukocyte depletion, and liposomal superoxide dismutase. J Heart Lung Transplant 10: 304-309, 1991.
12. Bando K, Pillai R, Cameron DE, et al: Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg 99: 873-877, 1990.
13. Schueler S, De Valeria PA, Hatanaka M, et al: Successful twenty-four-hour lung preservation with donor core cooling and leukocyte depletion in an orthotopic double lung transplantation model. J Thorac Cardiovasc Surg 104: 73-82, 1992.
14. Pillai R, Bando K, Schueler S, et al: Leukocyte depletion results in excellent heart-lung function after 12 hours of storage. Ann Thorac Surg 50: 211-214, 1990.
15. Palanzo D, Manley N, Montesano R, Yeisley G, Gordon D: Clinical evaluation of the LeukoGuard (LG-6) arterial line filter for routine open-heart surgery. Perfusion 8: 489-496, 1993.
16. Gu YJ, de Vries AJ, Vos P, Boonstra PW, van Oeveren W: Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit. Ann Thorac Surg 67: 604-609, 1999.
17. Sawa Y, Matsuda H, Shimazaki Y, et al: Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. J Thorac Cardiovasc Surg 108: 1125-1131, 1994.
18. Gu YJ, de Vries AJ, Boonstra PW, van Oeveren W: Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg 112: 494-500, 1996.
19. Scholz M, Simon A, Matheis G, et al: Leukocyte filtration fails to limit functional neutrophil activity during cardiac surgery. Inflamm Res 51: 363-368, 2002.
20. Matheis G, Scholz M, Simon A, et al: Timing of leukocyte filtration during cardiopulmonary bypass. Perfusion 16(Suppl): 31-37, 2001.
21. Alexiou C, Sheppard S, Smith D, Gibbs R, Haw MP: Effect of blood temperature on the efficacy of systemic leucodepletion during cardiopulmonary bypass: A prospective randomized clinical study. ASAIO J 51: 802-807, 2005.
22. Salamonsen RF, Anderson J, Anderson M, et al: Total leukocyte control for elective coronary bypass surgery does not improve short-term outcome. Ann Thorac Surg 79: 2032-2038, 2005.
23. Gott JP: Leukodepletion and aprotinin improve clinical outcome after extracorporeal circulation. Perfusion 16(Suppl): 5-9, 2001.
24. Stefanou DC, Gourlay T, Asimakopoulos G, Taylor KM: Leucodepletion during cardiopulmonary bypass reduces blood transfusion and crystalloid requirements. Perfusion 16: 51-58, 2001.
25. Nuttall GA, Erchul DT, Haight TJ, et al: A comparison of bleeding and transfusion in patients who undergo coronary artery bypass grafting via sternotomy with and without cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17: 447-451, 2003.
26. Nuttall GA, Oliver WC, Santrach PJ, et al: Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 94: 773-781; discussion 775A-776A, 2001.
27. Jadad AR, Moore RA, Carroll D, et al: Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17: 1-12, 1996.
28. Moher D, Cook DJ, Eastwood S, et al: Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354: 1896-1900, 1999.
29. Cochrane Reviewers' Handbook 4.2.1 [updated December 2003]. Chichester, John Wiley & Sons Ltd, 2004.
30. Egger M, Davey Smith G, Schneider M, Minder C: Bias in metaanalysis detected by a simple, graphical test. BMJ 315: 629-634, 1997.
31. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7: 177-188, 1986.
32. Purkayastha S, Constantinides VA, Tekkis PP, et al: Laparoscopic vs. open surgery for diverticular disease: a meta-analysis of nonrandomized studies. Dis Colon Rectum 49: 446-463, 2006.
33. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 327: 557-560, 2003.
34. Higgins JP and Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558, 2002.
35. Egger M, Smith GD: Misleading meta-analysis. BMJ 310: 752-754, 1995.
36. Koskenkari J, Rimpilainen J, Biancari F, et al: Leukocyte depleting filter attenuates myocardial injury during elective coronary artery bypass surgery. Scand Cardiovasc J 39: 358-368, 2005.
37. Martens S, Matheis G, Wimmer-Greinecker G, et al: Heparin coating of the extracorporeal circuit combined with leukocyte filtration reduces coagulation activity, blood loss and blood product substitution. Int J Artif Organs 24: 484-488, 2001.
38. Smit JJ, de Vries AJ, Gu YJ, van Oeveren W: Efficiency and safety of leukocyte filtration during cardiopulmonary bypass for cardiac surgery. Transfus Sci 20: 151-165, 1999.
39. Sahlman A, Ahonen J, Salo JA, Ramo OJ: No impact of a leucocyte depleting arterial line filter on patient recovery after cardiopulmonary bypass. Acta Anaesthesiol Scand 45: 558-563, 2001.
40. Fabbri A, Manfredi J, Piccin C, et al: Systemic leukocyte filtration during cardiopulmonary bypass. Perfusion 16(Suppl): 11-18, 2001.
41. Efstathiou A, Vlachveis M, Tsonis G, et al: Does leukodepletion during elective cardiac surgery really influence the overall clinical outcome? J Cardiovasc Surg (Torino) 44: 197-204, 2003.
42. Chen YF, Tsai WC, Lin CC, et al: Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass. Ann Thorac Surg 78: 634-642; discussion 642-633, 2004.
43. Leal-Noval SR, Amaya R, Herruzo A, et al: Effects of a leukocyte depleting arterial line filter on perioperative morbidity in patients undergoing cardiac surgery: A controlled randomized trial. Ann Thorac Surg 80: 1394-1400, 2005.
44. Samankatiwat P, Samartzis I, Lertsithichai P, et al: Leucocyte depletion in cardiopulmonary bypass: A comparison of four strategies. Perfusion 18: 95-105, 2003.
45. de Vries AJ, Gu YJ, Post WJ, et al: Leucocyte depletion during cardiac surgery: a comparison of different filtration strategies. Perfusion 18: 31-38, 2003.
46. Morris SJ: Leukocyte reduction in cardiovascular surgery. Perfusion 16: 371-380, 2001.
47. Baksaas ST, Flom-Halvorsen HI, Ovrum E, et al: Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery. Perfusion 14: 107-117, 1999.
48. Ortolano GA, Aldea GS, Lilly K, et al: A review of leukofiltration in cardiac surgery: The time course of reperfusion injury may facilitate study design of anti-inflammatory effects. Perfusion 17(Suppl): 53-62, 2002.
49. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C: Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 28: 1-9, 1999.
50. Olivencia-Yurvati AH, Wallace N, Ford S, Mallet RT: Leukocyte filtration and aprotinin: Synergistic anti-inflammatory protection. Perfusion 19(Suppl 1): S13-S19, 2004.
51. Olivencia-Yurvati AH, Ferrara CA, Tierney N, Wallace N, Mallet RT: Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopulmonary bypass. Perfusion 18(Suppl 1): 23-31, 2003.
52. Warren O, Alexiou C, Massey R, et al: The effects of various leukocyte filtration strategies in cardiac surgery. Eur J Cardiothorac Surg 2007. doi: 10.1016/j.ejcts.2006.12.034.
53. Johnson D, Thomson D, Mycyk T, Burbridge B, Mayers I: Depletion of neutrophils by filter during aortocoronary bypass surgery transiently improves postoperative cardiorespiratory status. Chest 107: 1253-1259, 1995.
54. Chen YF, Tsai WC, Lin CC, et al: Leukocyte depletion attenuates expression of neutrophil adhesion molecules during cardiopulmonary bypass in human beings. J Thorac Cardiovasc Surg 123: 218-224, 2002.
55. The American Society of Extracorporeal Technology. Guidelines on Perfusion Standards. Available at: http://www.amsect.org/. Accessed January 10, 2007.
56. The Society of Clinical Perfusion Scientists of Great Britain and Ireland. Recommendations for Standards of Monitoring and Alarms during Cardiopulmonary Bypass. Available at: http://www.scps.org.uk/. Accessed January 10, 2007.
57. Shapiro S: Meta-analysis/Shmeta-analysis. Am J Epidemiol 140: 771-778, 1994.
58. Petitti DB: Of babies and bathwater. Am J Epidemiol 140: 779-782, 1994.